RBL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.90465437760668E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.43289999865459E-08 |
Normal-vs-Stage2 |
1.235610E-02 |
Normal-vs-Stage3 |
3.08875147680965E-12 |
Normal-vs-Stage4 |
1.65345515057425E-12 |
Stage1-vs-Stage2 |
5.293400E-01 |
Stage1-vs-Stage3 |
7.955700E-03 |
Stage1-vs-Stage4 |
8.840600E-04 |
Stage2-vs-Stage3 |
6.363700E-02 |
Stage2-vs-Stage4 |
2.062500E-02 |
Stage3-vs-Stage4 |
4.285600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.01489927573084E-11 |
Normal-vs-AfricanAmerican |
7.47829576042136E-11 |
Normal-vs-Asian |
2.936400E-02 |
Caucasian-vs-AfricanAmerican |
1.061560E-01 |
Caucasian-vs-Asian |
7.221200E-01 |
AfricanAmerican-vs-Asian |
2.549200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.65989444411707E-12 |
Normal-vs-Female |
1.11529996349446E-09 |
Male-vs-Female |
3.127600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.91549999884711E-08 |
Normal-vs-Age(41-60Yrs) |
2.400700005456E-08 |
Normal-vs-Age(61-80Yrs) |
1.90636395558386E-12 |
Normal-vs-Age(81-100Yrs) |
3.85360000021429E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.221220E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.063000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.507600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.295900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.297030E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.862600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.608200E-01 |
Normal-vs-Grade 2 |
5.84559999960987E-07 |
Normal-vs-Grade 3 |
1.62680979798324E-12 |
Normal-vs-Grade 4 |
1.62481139653892E-12 |
Grade 1-vs-Grade 2 |
2.061200E-01 |
Grade 1-vs-Grade 3 |
1.680520E-03 |
Grade 1-vs-Grade 4 |
6.19060000000005E-05 |
Grade 2-vs-Grade 3 |
9.573200E-04 |
Grade 2-vs-Grade 4 |
3.59039999953126E-07 |
Grade 3-vs-Grade 4 |
3.159000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.77744999999563E-05 |
Normal-vs-ccB subtype |
3.71529473852661E-11 |
ccA subtype-vs-ccB subtype |
1.658770E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.15719994592456E-09 |
Normal-vs-N1 |
1.15670000022661E-07 |
N0-vs-N1 |
7.308100E-02 |
|
|